Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hui-Juan Zhong

Showing results (1-10 of 17) with videos related to

Pageof 2
Sort By:
Biochimica Et Biophysica Acta. Molecular Basis of Disease|April 21, 2023
A nuclear NKRF interacting long noncoding RNA controls EBV eradication and suppresses tumor progression in natural killer/T-cell lymphomaWen-Fang Wang, Hui-Juan Zhong, Shu Cheng, et al.
The Oncologist|June 10, 2025
Baseline total lesion glycolysis identifies high-risk patients with immunosuppressive signatures in early-stage natural killer/T-cell lymphomaXiao Gao, Jie Xiong, Xin-Yun Huang, et al.
Molecular Cancer|March 31, 2019
MiR155 sensitized B-lymphoma cells to anti-PD-L1 antibody via PD-1/PD-L1-mediated lymphoma cell interaction with CD8+T cellsZhong Zheng, Rui Sun, Hui-Jin Zhao, et al.
Biomarker Research|July 25, 2022
Dynamic change of soluble interleukin-2 receptor distinguished molecular heterogeneity and microenvironment alterations in diffuse large B-cell lymphomaYu-Jia Huo, Peng-Peng Xu, Li Wang, et al.
Ebiomedicine|October 24, 2017
A Phase II Study of Methotrexate, Etoposide, Dexamethasone and Pegaspargase Sandwiched with Radiotherapy in the Treatment of Newly Diagnosed, Stage IE to IIE Extranodal Natural-Killer/T-Cell Lymphoma, Nasal-TypePeng-Peng Xu, Jie Xiong, Shu Cheng, et al.
Advances in Radiation Oncology|November 6, 2024
Treatment Outcomes and Prognostic Factors of Chemotherapy Combined With Radiation Therapy for Patients With Early-Stage Extranodal Natural Killer/T-Cell LymphomaShu-Bei Wang, Jia-Yi Chen, Wei-Li Zhao, et al.
Biochemical and Biophysical Research Communications|October 3, 2017
miR-758-5p regulates cholesterol uptake via targeting the CD36 3'UTRBi-Rong Li, Lin-Qin Xia, Jing Liu, et al.
Ebiomedicine|February 4, 2017
B-cell Function Gene Mutations in Diffuse Large B-cell Lymphoma: A Retrospective Cohort StudyPeng-Peng Xu, Hui-Juan Zhong, Yao-Hui Huang, et al.
Practical Radiation Oncology|July 6, 2026
Locoregional recurrence patterns and prognostic outcomes in early-stage natural killer/T-cell lymphoma treated with sandwich chemoradiotherapy: A post hoc analysis of a randomized controlled trialShu-Bei Wang, Jia-Yi Chen, Qi Song, et al.
Journal of Experimental & Clinical Cancer Research : CR|June 23, 2017
MiR21 sensitized B-lymphoma cells to ABT-199 via ICOS/ICOSL-mediated interaction of Treg cells with endothelial cellsZhong Zheng, Peng-Peng Xu, Li Wang, et al.
Pageof 2

Showing results (1-10 of 17) with videos related to

Sort By:
Pageof 2
Biochimica Et Biophysica Acta. Molecular Basis of Disease|April 21, 2023
A nuclear NKRF interacting long noncoding RNA controls EBV eradication and suppresses tumor progression in natural killer/T-cell lymphomaWen-Fang Wang, Hui-Juan Zhong, Shu Cheng, et al.
The Oncologist|June 10, 2025
Baseline total lesion glycolysis identifies high-risk patients with immunosuppressive signatures in early-stage natural killer/T-cell lymphomaXiao Gao, Jie Xiong, Xin-Yun Huang, et al.
Molecular Cancer|March 31, 2019
MiR155 sensitized B-lymphoma cells to anti-PD-L1 antibody via PD-1/PD-L1-mediated lymphoma cell interaction with CD8+T cellsZhong Zheng, Rui Sun, Hui-Jin Zhao, et al.
Biomarker Research|July 25, 2022
Dynamic change of soluble interleukin-2 receptor distinguished molecular heterogeneity and microenvironment alterations in diffuse large B-cell lymphomaYu-Jia Huo, Peng-Peng Xu, Li Wang, et al.
Ebiomedicine|October 24, 2017
A Phase II Study of Methotrexate, Etoposide, Dexamethasone and Pegaspargase Sandwiched with Radiotherapy in the Treatment of Newly Diagnosed, Stage IE to IIE Extranodal Natural-Killer/T-Cell Lymphoma, Nasal-TypePeng-Peng Xu, Jie Xiong, Shu Cheng, et al.
Advances in Radiation Oncology|November 6, 2024
Treatment Outcomes and Prognostic Factors of Chemotherapy Combined With Radiation Therapy for Patients With Early-Stage Extranodal Natural Killer/T-Cell LymphomaShu-Bei Wang, Jia-Yi Chen, Wei-Li Zhao, et al.
Biochemical and Biophysical Research Communications|October 3, 2017
miR-758-5p regulates cholesterol uptake via targeting the CD36 3'UTRBi-Rong Li, Lin-Qin Xia, Jing Liu, et al.
Ebiomedicine|February 4, 2017
B-cell Function Gene Mutations in Diffuse Large B-cell Lymphoma: A Retrospective Cohort StudyPeng-Peng Xu, Hui-Juan Zhong, Yao-Hui Huang, et al.
Practical Radiation Oncology|July 6, 2026
Locoregional recurrence patterns and prognostic outcomes in early-stage natural killer/T-cell lymphoma treated with sandwich chemoradiotherapy: A post hoc analysis of a randomized controlled trialShu-Bei Wang, Jia-Yi Chen, Qi Song, et al.
Journal of Experimental & Clinical Cancer Research : CR|June 23, 2017
MiR21 sensitized B-lymphoma cells to ABT-199 via ICOS/ICOSL-mediated interaction of Treg cells with endothelial cellsZhong Zheng, Peng-Peng Xu, Li Wang, et al.
Pageof 2